Immediate Impact

1 from Science/Nature 66 standout
Sub-graph 1 of 24

Citing Papers

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
1 intermediate paper

Works of A. Khan being referenced

A phase 2, randomized, double-blind, placebo-controlled study of senolytic molecule UBX0101 in the treatment of painful knee osteoarthritis
2021
Correlation Between Postoperative Infective Complications and Long-Term Outcomes After Hepatic Resection for Colorectal Liver Metastasis
2009

Author Peers

Author Last Decade Papers Cites
A. Khan 609 468 300 413 44 1.0k
Takafumi Kumamoto 583 543 288 458 78 1.1k
Michio Ueda 598 471 230 346 54 947
Tetsunosuke Shimizu 435 522 286 532 71 1.2k
Koji Komeda 519 588 362 627 74 1.3k
Jeffery Chakedis 474 640 339 238 41 1.2k
Thierry Delaunoit 795 451 354 357 43 1.2k
Paolo Massucco 698 528 349 343 36 1.1k
Suguru Yamashita 681 660 424 748 58 1.3k
Kengo Fukuzawa 426 526 266 364 65 1.0k
Patryk Kambakamba 374 527 235 303 44 880

All Works

Loading papers...

Rankless by CCL
2026